Gene · 4082
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics as a tool to improve novel insights into skin diseases: what we know and where we should be going. | Front Surg | 2022 | 36338621 | PubTator, text mining | PubMed |
| Neuroprotective effects of donepezil against Aβ25-35-induced neurotoxicity. | Eur J Med Res | 2022 | 36307893 | PubTator, text mining | PubMed |
| Calmodulin in Paramecium: Focus on Genomic Data. | Microorganisms | 2022 | 36296191 | PubTator, text mining | PubMed |
| Wound Infections in Adult Patients after Berlin Heart® EXCOR Biventricular Assist Device Implantation. | Life (Basel) | 2022 | 36294985 | PubTator, text mining | PubMed |
| The orchestrated signaling by PI3Kα and PTEN at the membrane interface. | Comput Struct Biotechnol J | 2022 | 36284707 | PubTator, text mining | PubMed |
| Determining biomarkers for evaluation and diagnosis of hereditary angioedema. | Clin Transl Allergy | 2022 | 36254341 | PubTator, text mining | PubMed |
| Claudin-4 localization in epithelial ovarian cancer. | Heliyon | 2022 | 36237976 | PubTator, text mining | PubMed |
| Small extracellular vesicles as a multicomponent biomarker platform in urinary tract carcinomas. | Front Mol Biosci | 2022 | 36237572 | PubTator, text mining | PubMed |
| The Role of MARCKS in Metastasis and Treatment Resistance of Solid Tumors. | Cancers (Basel) | 2022 | 36230850 | PubTator, text mining | PubMed |
| Establishment and evaluation of module-based immune-associated gene signature to predict overall survival in patients of colon adenocarcinoma. | J Biomed Sci | 2022 | 36229806 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals potential hub genes and therapeutic drugs in an acquired lymphedema model. | Gland Surg | 2022 | 36221279 | PubTator, text mining | PubMed |
| miRNA effects on gut homeostasis: therapeutic implications for inflammatory bowel disease. | Trends Immunol | 2022 | 36220689 | PubTator, text mining | PubMed |
| Chemical Proteomics Reveals Protein Tyrosination Extends Beyond the Alpha-Tubulins in Human Cells. | Chembiochem | 2022 | 36218090 | PubTator, text mining | PubMed |
| CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression. | Front Immunol | 2022 | 36211403 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36197221 | PubTator, text mining | PubMed |
| Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer. | J Biol Chem | 2022 | 36183837 | PubTator, text mining | PubMed |
| The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. | Theranostics | 2022 | 36168628 | PubTator, text mining | PubMed |
| Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease. | Front Aging Neurosci | 2022 | 36158539 | PubTator, text mining | PubMed |
| Microenvironment components and spatially resolved single-cell transcriptome atlas of breast cancer metastatic axillary lymph nodes. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 36148946 | PubTator, text mining | PubMed |
| MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer. | Cells | 2022 | 36139501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4082/papers?page=17